Home › Chemotherapy › Docetaxel (Taxotere, Docetax, Daxotel): — What to Expect

Chemotherapy drugs

Docetaxel (Taxotere, Docetax, Daxotel): What to Expect

Medically reviewed by Dr. Owais Mohammed, Medical Oncologist · Last reviewed September 2026

Docetaxel is a chemotherapy medicine given by drip, used in breast, lung, prostate and several other cancers. Its most distinctive side effects — nail changes, watering eyes and fluid build-up — are ones most patients are not warned about before treatment starts.

Medically reviewed by Dr. Owais Mohammed, Medical Oncologist · Last reviewed September 2026

Prescription-only medicine.

Docetaxel is a prescription-only medicine, given by intravenous infusion under the supervision of a specialist oncologist in a hospital or clinic setting. Nothing on this page can be used to start, modify or stop any treatment. All decisions about this medicine must be made by a qualified doctor with full knowledge of your individual case. It is not suitable for everyone — see who this is not for below.

Talk to an oncologist

Leave your details and a member of the oncology team will call you back to answer questions about your treatment plan.

No charge for the call, and no obligation to book anything.

412Chemotherapy pages, written and reviewed

17Oncologists on the panel

10Centres across Hyderabad

41Locations across two states

In short

Docetaxel is a taxane chemotherapy given by intravenous drip. It works by locking the protein structures cancer cells need to pull apart when they divide, causing those cells to die. Its most distinctive side effects are nail changes, watering eyes and fluid retention — effects that build gradually over cycles and are rarely explained to patients before treatment begins.

In detail

What is docetaxel and how does it work?

Docetaxel belongs to a group of chemotherapy medicines called taxanes. It is given by intravenous drip, usually in a day care setting, and is used in breast, lung, prostate, stomach and head and neck cancers, among others.

It works by disrupting the protein scaffolding inside dividing cells. When a cancer cell tries to split, it needs to pull its duplicated chromosomes apart using structures called microtubules. Docetaxel locks these in place, so division cannot complete and the cell dies.

This same effect on fast-dividing normal cells is why side effects occur — cells in hair follicles, nail beds, the gut lining and bone marrow are all affected to varying degrees.

Step by step

What happens on the day of your infusion?

Steroid tablets in the days before

You will be given a steroid — most often dexamethasone — to take the day before, the day of, and the day after your infusion. This is not optional. Docetaxel can cause severe fluid retention and allergic-type reactions, and the steroid substantially reduces both risks. If you cannot take the tablets for any reason, tell your team before the infusion, not afterwards.

Blood count check before the drip starts

Your team checks your neutrophil count before each cycle. If it is below a safe level, your cycle will be delayed rather than risked. This is a routine precaution, not a sign that something has gone wrong.

Anti-allergy medicine through the line

A further dose of antihistamine or steroid is given through the drip in the minutes before docetaxel starts. This is standard practice to reduce the chance of an immediate infusion reaction.

The infusion itself

Docetaxel is given over approximately one hour. A nurse will observe you throughout. If you feel sudden flushing, chest tightness or difficulty breathing, say so immediately — reactions are rare but are managed quickly when reported at once.

Short observation period before going home

You will be monitored briefly after the drip finishes before leaving. The most significant side effects — fatigue, low blood counts, gut symptoms — develop in the days that follow, not during the infusion itself.

Eligibility

Who is docetaxel not suitable for?

Docetaxel is not suitable for every patient, even among those with cancers it is commonly used to treat. Eligibility is determined by your oncologist on the basis of your individual diagnosis, organ function and overall fitness.

Severe liver impairment: docetaxel is processed by the liver, and significantly reduced liver function increases the risk of serious toxicity.
Neutrophil count below the safe threshold before a cycleBlood counts are checked before every infusion, and a cycle will not proceed if they are too low.
Known severe hypersensitivity to polysorbate 80, the solvent docetaxel is formulated with.
Performance status too poor to tolerate the treatment safelyYour oncologist assesses this before each cycle, not only at the start.
Pregnancy: docetaxel is harmful to the developing foetus.

These are the most common reasons docetaxel is not used or is held. The decision in every case is made individually by your oncologist.

Want to talk this through with an oncologist?

Leave your number and an oncology coordinator will call you back at a time that suits you.

In detail

Why do nails, eyes and ankles change on docetaxel?

These three effects are docetaxel's most distinctive side effects and the ones most often not explained in advance. They tend to develop gradually across treatment cycles rather than appearing immediately after the first infusion.

Nail changes — darkening, discoloration or the nail lifting away from the nail bed — happen because the cells that generate new nail tissue are sensitive to the medicine. You may notice tenderness before any visible change appears. Tell your team: protective measures exist, and a dermatology referral is sometimes appropriate.

Watering eyes happen because docetaxel can narrow the small drainage ducts inside the eyelids. Tears overflow instead of draining normally. This can continue after treatment ends. If it bothers you during treatment, or does not settle within a few months of finishing, ask for an eye specialist referral.

Fluid retention — swollen ankles, legs or abdomen, unexpected weight gain — is cumulative, meaning it tends to worsen with each cycle. The steroid premedication reduces but does not eliminate it. Report any rapid or unexplained weight gain between cycles, and tell your team immediately if you become short of breath alongside any swelling.

Worth knowing

Did you know?

Watering eyes from docetaxel can persist long after the last dose because the tear drainage ducts inside the eyelids have narrowed — not because the medicine is still circulating.

ESMO guidance on taxane toxicities recommends ophthalmology review if tearing does not improve within a few months of finishing treatment, as procedures exist to open narrowed ducts — and earlier referral preserves more options.

Source: ESMO Clinical Practice Guidelines: Management of Chemotherapy-Related Toxicities

Still have a question about your treatment? Tell us what is on your chart and an oncologist will explain what it means for you, what to expect and what your schedule is likely to look like.

Talk to an oncologist 1800 202 8726

Common questions

Frequently asked questions

Why do I need to take steroid tablets before each cycle?

The steroid — most often dexamethasone — reduces the risk of two specific problems. First, it lowers the chance of a severe allergic-type reaction during the infusion. Second, it limits fluid retention, which is a cumulative effect of docetaxel that can become significant over multiple cycles. The course is usually taken the day before, the day of and the day after your infusion. Missing doses raises the risk of both problems. If you cannot take them for any reason — nausea, another medicine, anything else — tell your team before the infusion goes ahead, not after.

Will my nails go back to normal after treatment ends?

For most people, yes — nails grow back gradually once treatment has finished. Because nails grow slowly, full recovery can take several months. During treatment, keeping nails short, wearing gloves for household tasks and avoiding anything that catches or lifts the nail can limit damage. If a nail becomes painful, shows signs of infection or lifts significantly from the nail bed, tell your team rather than trying to treat it yourself. A dermatology referral is sometimes the right next step.

Will I lose all my hair on docetaxel?

Hair loss is very common with docetaxel and is often more complete than with some other chemotherapy medicines. It typically begins two to three weeks after the first cycle and can affect scalp hair, eyebrows, eyelashes and body hair. For most people hair regrows after treatment ends, though the texture or colour may differ at first. Scalp cooling during infusion is sometimes used to try to reduce loss; ask your team whether it is an option in your situation and what the evidence suggests for your specific treatment.

How do I know if the swelling is becoming serious?

Mild ankle swelling that does not worsen and improves when your feet are raised is usually manageable. Call your team the same day if your weight increases noticeably over a short period, if your legs become very swollen or tight, if you notice abdominal swelling, or if you become short of breath alongside any swelling. Breathlessness with swelling can mean fluid near the lungs and needs urgent review. Your team weighs you before each cycle as routine monitoring, but do not wait for that appointment if things change suddenly.

What is the difference between docetaxel and paclitaxel?

Both belong to the taxane group and work by the same mechanism — blocking the protein structures cells need to divide. The differences lie in formulation, schedule and side effect profile. Paclitaxel is associated more strongly with nerve symptoms in the hands and feet. Docetaxel is associated more strongly with nail changes, watering eyes and fluid retention. Your oncologist chooses between them based on your cancer type, your overall health and which side effects you are better placed to tolerate. The choice is a clinical judgement made on your individual situation.

Will the watering eyes settle on their own after treatment?

For many people, yes — tearing reduces gradually after treatment ends as the drainage ducts recover. For some, the narrowing persists and eyes continue to water for months after the last dose. If it does not improve within a few months of finishing, ask your oncologist to refer you to an ophthalmologist. Procedures exist to open narrowed ducts, and earlier referral leaves more options available. Do not assume it will always resolve on its own — if it is affecting your daily life or your vision, tell your team.

Who would be treating you

The medical oncologists on the CION panel

Chemotherapy is prescribed, dosed and supervised by a medical oncologist. These are the six on the CION panel.

Dr. Naresh Gundu

Medical Oncologist

MBBS · DNB Internal Medicine (Sir Gangaram, New Delhi) · DM Medical Oncology (AIIMS)

Call Book appointment

Dr. C. Raghavendra Reddy

Medical Oncologist

MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Kukatpally

Call Book appointment

Dr. Bharati Devi Gorantla

Medical Oncologist

MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK)

Call Book appointment

Dr. Owais Mohammed

Medical Oncologist

Call Book appointment

Dr. T. Raghavender Reddy

Medical Oncologist

MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · L.B. Nagar

Call Book appointment

Dr. N. Kiranmayee

Medical Oncologist

Call Book appointment

Which oncologist you see depends on the centre nearest you and on what your treatment involves. Tell us where you are and we will point you to the closest.

Talk it through

Reading about a medicine is not the same as being told what to expect

This page explains what the medicine does in general. What it cannot tell you is how your own regimen was chosen, what your schedule looks like, or which of these effects apply to you — that needs your reports and a conversation.

Free first consultation Second opinion on an existing plan 10 centres across Hyderabad

Speak to an oncologist

Share your details and the team will call you back to arrange a consultation or a second opinion.

Bring your reports if you have them. If you do not, come anyway.

list of links to other editorial pages, which base contract s2.1 permits explicitly. It contains no form, no phone number and no CTA button, so it does not turn this page into an advertisement. Generated by scripts/hub_update.py --include-out. -->

Full index